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Sophora alopecuroides seed (SAS) was extracted with chloroform, ethanol and 
distilled water. The TLC result showed the presence of alkaloids in all of the extracts 
and the total alkaloid contents was 7.56%. The alkaloids were separated and identified 
with Q-TQF MS with known reference standard and were found that Sophora 
alopecuroides seed contained alkaloids namely sophocarpine, matrine, baptifoline, 
oxysophocarpine, oxymatrine, sophocarpine dimer, oxysophocarpine dimer, oxymatrine 
dimer and sophoranol-N-oxide dimer. The in vitro bioassays were performed to 
determine the antioxidant activity and glycogen phosphorylase enzyme inhibition 
activity of Sophora alopecuroides seed in ethanol and water extracts. In all of the 
bioassays, ethanol extract had showed highest activities. In DPPH assay the IC50 value 
of ethanol extract was 155.33 ± 0.06 μg/ml while in FRAP assay the IC50 value of 
ethanol extract was 9.71 ± 0.02 μg/ml. In GPa enzyme assay the IC50 of ethanol 
Sophora alopecuroides seed extract was 581.61 μg/ml. Acute toxicity of ethanol 
Sophora alopecuroides seed extract was tested at increasing dose level in non-diabetic 
rats and no toxic effects were observed in male rats at a dose of 5 g/kg body weight. The 
ethanol Sophora alopecuroides seed extract at the dose of 500 mg/kg was capable of 
decreasing the glycemia of non-diabetic rats during an oral glucose tolerance test 
(OGTT). The treatment with SAS at the dose of 500 mg/kg to the diabetic rats for 28 
days decreased fasting blood glucose levels significantly compared to the 0
th
 day.  The 
95% ethanol SAS extract at the dose of 250 mg/kg and 500 mg/kg body weight 
significantly (*P < 0.05) decreased serum triglycerides and total cholesterol levels, and 
increased serum HDL levels compared to the diabetic control. Therefore, these results 






Biji Sophora alopecuroides (SAS) telah diekstrakkan dengan klorofom, etanol 
dan air suling. Keputusan Keratan Lapisan Nipis (KLN) menunjukan kehadiran alkaloid 
didalam kesemua ekstrak and jumlah kandungan alkaloid adalah 7.56%. Alkaloid telah 
diasingkan dan dikenalpastikan menggunakan Q-TQF MS dengan rujukkan piawai dan 
didapati mengandungi alkaloid sophocarpine, matrine, baptifoline, oxysophocarpine, 
oxymatrine, sophocarpine dimer, oxysophocarpine dimer, oxymatrine dimer dan 
sophoranol-N-oxide dimer. Bioasei in vitro telah dijalankan untuk menentukan aktiviti 
antioksidan dan aktiviti perencatan enzim fosforilase ekstrak etanol dan air biji Sophora 
alopecuroides. Dalam kesemua bioasei, ekstrak etanol menunjukan aktivit tertinggi. 
Dalam asei DPPH nilai IC50 ekstrak etanol adalah 155.33 ± 0.06 ug/ml manakala dalam 
asei FRAP nilai IC50 ekstrak etanol adalah 9.71 ± 0.02 ug/ml. Didalam asei enzim GPa 
IC50 ekstrak etanol biji Sophora alopecuroides adalah 581.61 ug/ml. Ketoksikan akut 
ekstrak etanol biji Sophora alopecuroides telah diujikan pada paras dos menaik dalam 
tikus tak-dibetik dan tiada kesan ketoksikan dilihat di tikus jantan pada dos 5 g/kg berat 
badan. Ekstrak etanol biji Sophora alopecuroides pada dos 500 mg/kg berkebolehan 
menurunkan glisemia tikus tak-dibetik semasa ujian oral ketahanan glukosa (OGTT). 
Perlakuan dengan SAS pada dos 500mg/kg tikus diabetic signifikan merendahkan paras 
glukosa berbanding pada hari 0. Ekstrak 95% etanol SAS pada dos 250 mg/kg dan 500 
mg/kg berat badan menurun signifikan (*P<0.05) dengan serum trigliserida dan jumlah 
paras kolesterol dan meningkatkan paras serum HDL berbanding kawalan diabetik. 
Oleh itu, keputusan ini mengesahkan penggunaan traditional biji Sophora alopecuroides 
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